Samrat Pharmachem Complete Financial Statements
SAMRATPH • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Samrat Pharmachem (SAMRATPH).
Downloads include all available records across all periods.
For market performance, see the
SAMRATPH stock price today
.
Profitability Ratios
Net Profit Margin
2.44%
2025 data
EBITDA Margin
3.83%
2025 data
Operating Margin
4.00%
2025 data
Return on Assets
5.74%
2025 data
Return on Equity
9.72%
2025 data
Balance Sheet Ratios
Debt to Equity
1.69
2025 data
Equity Ratio
59.02%
2025 data
Asset Turnover
2.35
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Revenue Growth
+1.0%
Year-over-Year
Net Profit Growth
-71.4%
Year-over-Year
EBITDA Growth
-54.5%
Year-over-Year
Expense Growth
+3.3%
Year-over-Year
Equity Growth
+10.8%
Year-over-Year
Operating Cash Flow Growth
-211.1%
Year-over-Year
Financing Cash Flow Growth
+109.1%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 290 | 287 | 283 | 311 | 222 | 180 | 138 | 112 | 93 | 71 | 62 | 48 |
| Expenses | 285 | 276 | 279 | 287 | 198 | 170 | 131 | 108 | 87 | 67 | 61 | 46 |
| EBITDA | 5 | 11 | 4 | 24 | 25 | 9 | 7 | 4 | 6 | 4 | 1 | 2 |
| Operating Profit Margin % | 2.00% | 4.00% | 1.00% | 8.00% | 11.00% | 5.00% | 5.00% | 3.00% | 6.00% | 5.00% | 2.00% | 2.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 3 | 10 | 3 | 23 | 24 | 7 | 6 | 2 | 5 | 3 | 0 | 1 |
| Tax | 1 | 3 | 0 | 6 | 6 | 2 | 2 | 1 | 2 | 1 | 0 | 0 |
| Net Profit | 2 | 7 | 2 | 17 | 17 | 5 | 4 | 2 | 3 | 2 | 0 | 0 |
| Earnings Per Share (₹) | 5.10 | 23.02 | 7.00 | 53.83 | 55.62 | 17.26 | 13.71 | 4.97 | 10.41 | 5.68 | 0.97 | 1.02 |
Related Pages for Samrat Pharmachem
Additional stock information and data for SAMRATPH
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 122 | 122 | 117 | 85 | 57 | 58 | 40 | 41 | 36 | 36 | 26 |
| Current Assets | 103 | 103 | 99 | 71 | 47 | 50 | 33 | 33 | 28 | 28 | 19 |
| Fixed Assets | 11 | 11 | 11 | 10 | 9 | 7 | 7 | 7 | 7 | 7 | 7 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Investments | 4 | 3 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 |
| Other Assets | 107 | 108 | 104 | 75 | 48 | 50 | 33 | 34 | 29 | 27 | 19 |
| LIABILITIES | |||||||||||
| Total Liabilities | 122 | 122 | 117 | 85 | 57 | 58 | 40 | 41 | 36 | 36 | 26 |
| Current Liabilities | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 2 | 2 | 1 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 72 | 65 | 63 | 47 | 30 | 24 | 20 | 19 | 15 | 14 | 14 |
| Share Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Reserves & Surplus | 69 | 62 | 60 | 44 | 27 | 21 | 17 | 15 | 12 | 11 | 10 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -10 | 9 | -9 | 18 | 5 | -1 | 2 | 0 | -3 | 0 | -1 |
| Investing Activities | 0 | 0 | -3 | -1 | -3 | -2 | 2 | -2 | 1 | -2 | 0 |
| Financing Activities | 1 | -11 | 10 | -2 | -2 | 2 | -4 | 2 | 1 | 2 | 0 |
| Net Cash Flow | -10 | -2 | -3 | 15 | 0 | -1 | 1 | -1 | -1 | 0 | 0 |